Team (LRL-CAT) beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly Company, which operates the facility.
Assigning valid functions to proteins identified in genome projects is challenging: overprediction and database annotation errors are the principal concerns 1 . We and others 2 are developing computationguided strategies for functional discovery with 'metabolite docking' to experimentally derived 3 or homology-based 4 three-dimensional structures. Bacterial metabolic pathways often are encoded by 'genome neighbourhoods' (gene clusters and/or operons), which can provide important clues for functional assignment. We recently demonstrated the synergy of docking and pathway context by 'predicting' the intermediates in the glycolytic pathway in Escherichia coli 5 . Metabolite docking to multiple binding proteins and enzymes in the same pathway increases the reliability of in silico predictions of substrate specificities because the pathway intermediates are structurally similar. Here we report that structure-guided approaches for predicting the substrate specificities of several enzymes encoded by a bacterial gene cluster allowed the correct prediction of the in vitro activity of a structurally characterized enzyme of unknown function (PDB 2PMQ), 2-epimerization of trans-4-hydroxy-L-proline betaine (tHyp-B) and cis-4-hydroxy-D-proline betaine (cHyp-B), and also the correct identification of the catabolic pathway in which Hyp-B 2-epimerase participates. The substrate-liganded pose predicted by virtual library screening (docking) was confirmed experimentally. The enzymatic activities in the predicted pathway were confirmed by in vitro assays and genetic analyses; the intermediates were identified by metabolomics; and repression of the genes encoding the pathway by high salt concentrations was established by transcriptomics, confirming the osmolyte role of tHyp-B. This study establishes the utility of structure-guided functional predictions to enable the discovery of new metabolic pathways.
We have applied a structure-guided strategy using metabolite docking to multiple proteins and enzymes in a metabolic pathway to discover a previously undocumented reaction, 4R-hydroxyproline betaine 2-epimerase (Hyp-B 2-epimerase; Fig. 1a ), as well as the catabolic pathway by which tHyp-B is converted to a-ketoglutarate. The crystallographically determined unliganded structure of the uncharacterized 'target' as well as homology models for a binding protein and a second enzyme encoded by its genome neighbourhood were used to predict the Hyp-B 2-epimerase activity as well as those of downstream enzymes of the pathway.
The marine bacterium Pelagibaca bermudensis encodes an uncharacterized member of the enolase superfamily (National Center for Biotechnology Information GI number 114543141) in which two lysine residues of the TIM-barrel domain are positioned to function as acidbase catalysts [6] [7] [8] . The New York SGX Research Consortium determined its structure (PDB 2PMQ) because it shared less than 30% sequence identity with structurally characterized enolase superfamily members. The only ligand was the Mg 21 that stabilizes the enolate anion intermediate obtained by abstraction of the a-proton of a carboxylate substrate.
The active site is sequestered from solvent by two closed loops and was therefore suitable for virtual metabolite docking for substrate prediction ( Supplementary Fig. 1 ). Figure 2 shows the genome neighbourhoods of the gene encoding 2PMQ (hpbD; Hyp-B 2-epimerase from its functional characterization (see below)) plus a putative Paracoccus denitrificans orthologue. The automated TrEMBL annotations ( Supplementary Table 1 ) fail to assign the in vitro activity of HpbD or to identify the metabolic pathway. P. bermudensis is not genetically tractable; we therefore studied P. denitrificans, which encodes one HpbD orthologue and two sets of orthologues of most of the genes neighbouring the P. bermudensis hpbD gene. Genome neighbourhoods are 'conserved' for other putative orthologues (about 20 can be identified in the sequence databases at http://sfld.rbvi.ucsf.edu/).
The in silico ligand docking library (87,098 members) included the KEGG metabolite library 9 as well as other potential enolase superfamily substrates such as dipeptides, N-acylated amino acids, acid sugars and the enolate anions obtained by abstraction of the a-proton (high-energy intermediates 10 ) (Methods). The library was docked in the active site of HpbD by using Glide SP, and energy scoring functions rank-ordered the members of the library according to binding affinity. The best-scoring molecules were enriched with amino acid derivatives, especially proline analogues and N-capped amino acid derivatives ( Fig. 3 ), permitting the prediction that HpbD is an amino acid racemase/epimerase, with the substrate probably having N-substitution.
The genome neighbourhood includes an ABC transporter with a periplasmic binding protein (HpbJ) annotated as binding 'glycine betaine/ L-proline'. The structure of a homologous binding protein with glycine betaine 11 (PDB 1R9L) was used as the homology model template (HpbJ and 1R9L share 48% sequence identity) (Methods). The binding site contains three tryptophan residues ( Fig. 1b ) that form a p-cation 'cage' for a quaternary ammonium (betaine), which may also be electrostatically stabilized by Glu 42, located 5.4 Å from the quaternary nitrogen. Thus, the homology model permitted the prediction that its ligand is a betaine. A library of 31 betaines was docked to the model; tHyp-B had the highest rank (Supplementary Table 2 ), so we predicted that HpbJ participates in the transport of tHyp-B. In addition, the HpbD active site contains Trp 320 and Asp 292, which are similarly positioned relative to the predicted binding pose of betaines (Fig. 1c ). The structural basis for the predicted specificity of HpbJ therefore refined the prediction that the substrate for HpbD is a proline betaine, for example tHyp-B.
A homology model was constructed for the Rieske-type protein (HpbB1) using a homologue (PDB 3N0Q) as the template (60% sequence identity; Fig. 1d ) (Methods). The active site resembled the binding sites in the betaine-binding proteins (aromatic residues and Glu 200); indeed, some Rieske-type proteins are betaine demethylases [12] [13] [14] (Supplementary Fig. 2 and Supplementary Table 3 ). We therefore predicted that the substrate is a small betaine. (While this work was in progress, the X-ray structure of a Rieske-type Pro-B demethylase from Sinorhizobium meliloti (PDB 3VCP) was published 15 ; its active site superimposed closely with our HpbB1 homology model.)
The results of library docking to the experimental apo structure of HpbD (2PMQ) and to homology models of HpbJ and HpbB1 enabled us to predict that HpbD uses Hyp-B or Pro-B as a substrate in a 1,1proton transfer reaction. The betaines Gly-B and carnitine also were candidates (although these would be substrates for virtual reactions; the a-carbons are prochiral). Although more than 25 functions have been assigned to members of the enolase superfamily, including N-succinylamino acid racemases and dipeptide epimerases, no amino acid or amino acid betaine was known to be a substrate 8 .
tHyp-B, L-Pro-B, Gly-B and carnitine were incubated with HpbD in D 2 O (Methods). The 1 H NMR spectra with tHyp-B, D-Pro-B and Gly-B revealed exchange of the a-proton with solvent deuterium (the latter being a virtual reaction); in addition, for tHyp-B, resonances associated with cHyp-B, the 2-epimer, were observed ( Supplementary Fig. 3 ). These results are expected for a 1,1-proton transfer reaction that equilibrates the configurations at carbon 2 of tHyp-B and Pro-B using two lysine acid-base catalysts.
The kinetic constants for tHyp-B and L-Pro-B were determined for both HpbD orthologues ( Fig. 4b ) (Methods). Although the k cat values are large, the K m values are also large, so the k cat /K m values are modest. Betaines, including tHyp-B, are osmoprotectants accumulated by many bacteria, including pelagic (P. bermudensis) and plant-associated (P. denitrificans) species, to survive osmotic stress [16] [17] [18] [19] [20] ; their intracellular concentrations can approach molar levels 21, 22 . We determined that the intracellular concentration of Hyp-B is 170 mM in P. denitrificans grown on glucose in the presence of 0.5 M NaCl and 20 mM tHyp-B (Methods). Hyp-B 2-epimerase therefore probably functions with a high intracellular concentration of tHyp-B, so the kinetic constants are both physiologically reasonable and expected 23 . That only four compounds were tested (tHyp-B, L-Pro-B, carnitine and Gly-B) and two have physiologically relevant kinetic constants confirms that pathway docking enables efficient functional prediction. The 1.70-Å structure of HpbD was determined in the presence of tHyp-B (Methods, Supplementary Fig. 4 and Supplementary Table 4 ). 
Pelagibaca bermudensis HTCC2601
Figure 2 | Genome contexts of HpbD in P. bermudensis and the orthologous genes in P. denitrificans. The genes encoding orthologues are highlighted with the same colour; the sequence identities relating orthologues in P. bermudensis and P. denitrificans are indicated. The ecological sources of tHyp-B would be seaweed (sargasso) for the Sargasso Sea bacterium P. bermudensis, and plants for the soil bacterium P. denitrificans.
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The ligand electron density, with elevated B-factors, was interpreted as a mixture of tHyp-B (substrate) and cHyp-B (product) (Supplementary Fig. 5 ). The betaine forms a p-cation interaction with Trp 320 and is proximal to Asp 292, similar to the interactions in the Gly-B periplasmic binding protein (Fig. 1c ). The predicted pose with D-Pro-B superimposes closely on the experimental pose, explaining the correct computation-based prediction of substrate specificity.
We also speculated that the binding proteins and enzymes encoded in the HpbD genome neighbourhoods constitute a catabolic pathway that degrades tHyp-B to a-ketoglutarate ( Fig. 4a) , with HpbD catalysing the first step in which tHyp-B is 2-epimerized to cHyp-B; that is, the in vivo activity of HpbD is Hyp-B 2-epimerase. Subsequently, HpbB1/HpbC1, the Rieske-type protein, catalyses the demethylation of cHyp-B to N-methyl cHyp; HpbA, a flavin-dependent enzyme, converts N-methyl cHyp to cHyp; HpbE, a D-amino acid oxidase, catalyses the oxidation of cHyp to its imino acid; HpbG, a member of the dihydrodipicolinate synthase superfamily 24 , catalyses the dehydration of the 4-OH group and 'hydrolysis' of the 5-amino group to a-ketoglutarate semialdehyde; and HpbF, an aldehyde dehydrogenase, catalyses the oxidation of a-ketoglutarate semialdehyde to a-ketoglutarate. This pathway would permit the utilization of tHyp-B as a carbon and nitrogen source. The activities predicted for HpbE and HpbG were described recently in pathways for tHyp catabolism in Pseudomonas aeruginosa, Pseudomonas putida and S. meliloti 25, 26 ; however, the sequences of HpbE and HpbG are so divergent (less than 35% sequence identity) that the cHyp oxidase and cHyp imino acid dehydratase/deaminase functions could not be assigned to the P. bermudensis and P. denitrificans enzymes without additional information ( Supplementary Fig. 6 ).
When tHyp-B is used as an osmoprotectant (sea water is about 0.6 M NaCl), its catabolism should be depressed to maintain high intracellular concentrations. However, in the absence of osmotic stress, bacteria should be able to catabolize tHyp-B as a carbon and nitrogen source. P. denitrificans utilizes both tHyp-B and cHyp-B as carbon and nitrogen sources at low salt concentrations, as expected if the genome encodes the proposed catabolic pathway (Methods). Moreover, tHyp-B alleviates growth inhibition at high salt concentration (0.5 M NaCl) in glucose medium, arguing that P. denitrificans uses tHyp-B as an osmoprotectant ( Supplementary Figs 7-9 ). Growth stimulation by tHyp-B in high-salt glucose medium could result from both osmoprotection and catabolism of tHyp-B. To address this possibility we used strain RPd4, which lacks the demethylases that convert the isomers of Hyp-B to the isomers of N-methyl Hyp and therefore cannot utilize tHyp-B or cHyp-B as a carbon source ( Supplementary Table 8 ). Strain RPd4 grew almost as well on high-salt glucose medium in the presence of tHyp-B or cHyp-B as did the culture without salt supplementation, but growth on highsalt glucose medium in the absence of tHyp-B or cHyp-B was strongly inhibited ( Supplementary Fig. 8 ). The results establish that tHyp-B and cHyp-B function as osmoprotectants.
We identified the metabolites obtained from tHyp-B at low salt concentrations (Methods). In addition to Hyp-B (21 mM; Supplementary Table 10 ), N-methyl Hyp and Hyp (the carbon-2 epimers cannot be distinguished), the predicted downstream D 1 -pyrroline-4-hydroxy-2-carboxylate, a-ketoglutarate semialdehyde and a-ketoglutarate were observed ( Supplementary Figs 10 and 11) . The metabolites were not detected with succinate as a carbon source. In high-salt glucose medium 
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containing tHyp-B, the intracellular concentration of Hyp-B was 170 mM (as expected for an osmolyte; Supplementary Table 10) ; however, its downstream metabolites were not detected. Thus, the flux through the pathway is regulated so that tHyp-B is not catabolized when it is needed as osmoprotectant 19, 20, 27 . No Hyp-B was detected in cells grown on high-salt glucose medium, establishing that P. denitrificans lacks an anabolic pathway for tHyp-B. We used quantitative PCR with reverse transcription (qRT-PCR) to investigate expression of the genes encoding the catabolic pathway (Methods and Supplementary Table 6 ). P. denitrificans encodes one orthologue of Hyp-B 2-epimerase (HpbD) and the FAD-dependent N-methyl Hyp demethylase but two orthologues of the remaining proteins and enzymes involved in the transport of tHyp-B and its catabolism (Fig. 2) Table 6 ). Transport of tHyp-B/cHyp-B is required for uptake as osmolytes as well as carbon and nitrogen sources; expression of their transporters is enhanced, whereas epimerization and demethylation are suppressed, thereby allowing tHyp-B/cHyp-B to be retained as osmolytes.
The genes encoding the P. denitrificans pathway were individually disrupted by the insertion of antibiotic-resistance cassettes (Methods and Supplementary Table 7 ). The growth phenotypes are consistent with the predicted functions (Supplementary Discussion).
Here we have used homology modelling and metabolite docking to several proteins encoded by a gene cluster to guide the in vitro assignment of the previously undocumented Hyp-B 2-epimerase activity to 2PMQ, a structure determined by the Protein Structure Initiative. With knowledge of the catalytic capabilities of enzyme superfamilies, we also predicted the pathway that catabolizes cHyp-B to a-ketoglutarate. These predictions were verified by metabolomics and genetics. Finally, we used transcriptomics to demonstrate that Hyp-B 2-epimerase is a 'switch' that determines whether the tHyp-B is accumulated as an osmolyte or catabolized as carbon and nitrogen source.
Orthologues of HpbD can be identified in 20 microbial species (http://sfld.rbvi.ucsf.edu/), so both the in vitro activity and the in vivo functional assignments identified in this study can be extended to these proteins and organisms. Moreover, we expect that the Hyp-B 2-epimerase activity assigned to HpbD will be used to facilitate the discovery of the in vitro activities and in vivo functions of uncharacterized homologues in the enolase superfamily.
We propose pathway docking as an efficient strategy for predicting in vitro enzymatic activities and in vivo physiological functions. Additional refinements and applications of this strategy are in progress.
METHODS SUMMARY
The metabolite library was docked into the unliganded structure of HpbD (2PMQ) with program Glide SP followed by rescoring with MM-GBSA. Homology models for HpbJ and HpbB1 were made by PLOP v. 25.0; the betaine library was docked into the model of HpbJ with Glide XP. Kinetic constants for HpbD were measured by quantifying the change in optical rotation. HpbD was expressed with a carboxyterminal hexahistidine tag; crystals were grown by sitting-drop vapour diffusion and flash-cooled in liquid nitrogen. Data were collected at the Advanced Photon Source beamline 31-ID (Lilly-CAT); the structure was determined by molecular replacement using the unliganded structure (2PMQ).
Metabolomics analyses by liquid chromatography Fourier transform mass spectrometry were performed with tHyp-B either as a sole source of carbon or as both an osmoregulant and the sole source of carbon 28 . Gene expression profiles were studied with a Roche LightCycler 480. P. denitrificans gene disruption mutants were generated by conjugation 29 or electroporation 30 .
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
Homology modelling and docking. Sequence similarity network analysis. All sequences from the MLE subgroup in the Structure-Function Linkage Database (SFLD) 7 were used in the MLE subgroup network analysis. BLAST analyses were performed with these sequences as queries in an all-by-all fashion. The details have been described previously 4 .
Sequences in the cHyp oxidase and Pyr4H2C deaminase networks were collected by BLAST, using red and blue dots in Supplementary Fig. 6 as queries, and 10 2100 as BLAST E-value cutoff. The Pythoscape v. 1.0 program 31 was used to make the two networks.
Homology modelling and docking. The models of HpbJ and HpbB1 were built with our in-house software Protein Local Optimization (PLOP, marketed as Prime by Schrödinger LLC). The template PDBs used for HpbJ and HpbB1 were 1R9L and 3N0Q, respectively. The sequence alignment of each pair of target and template was made by the L-INS-i method in MAFFT v. 6.925b (ref. 32 ). While constructing the models we included both the metal ions and the co-crystallized ligands (if any) from the templates. For docking, 2PMQ, the 1.72-Å X-ray apo structure of HpbD, was used. The structures were processed by Protein Preparation Wizard in Schrödinger Suite 2009 (ref. 33) before docking.
Two different libraries were used for docking in the active site of HpbD. The large metabolite library is the KEGG metabolite library plus potential substrates for members of the enolase superfamily not found in KEGG. The small library for focused docking to HpbD contained 31 betaines and betaine-like metabolites.
The KEGG metabolite library was generated by the following steps. First, we obtained 14,039 compounds from the KEGG COMPOUND database; then, we used LigPrep 34 in Schrödinger Suite 2009 to convert each compound from two dimensions to three dimensions and to enumerate up to 32 chiral forms. During this process, compounds with unspecified chemical groups (listed as 'R'), polymers and monatomic ions were automatically removed. Next, we removed compounds with molecular masses greater than 400 Da because we did not expect these to fit into the active site of HpbD, as well as duplicates generated by LigPrep preparation. We obtained 82,952 unique KEGG ligands.
Potential substrates for the enolase superfamily proteins include all dipeptides (formed by 20 standard amino acids), several types of N-capped (N-succinyl, N-acyl, N-formimino, N-formyl and N-carbamoyl) amino acids, acid sugars (monoacid sugars, diacid sugars, uronate sugars, 6-deoxy acid sugars and phospho sugars) and their corresponding enolates (that is, high-energy intermediates); these also were processed by LigPrep. After combining the KEGG metabolite library with these additional potential substrates for members of the enolase superfamily and removing duplicates, the library used for docking into the active site of HpbD contained 87,098 unique ligands.
The betaine library used for docking to the active site of HpbJ contains 31 betaines and betaine-like metabolites, including dimethylsulphoniopropionate (DMSP), ectoine, 5-hydroxyectoine and trigonelline; the compounds are listed in Supplementary Table 2 . The members of this library also were processed by LigPrep.
Two docking methods were used. Glide SP docking followed by MM-GBSA was used with HpbD; the details have been described previously 35 . The Glide XP docking method 36 was used with HpbJ. In vitro activity measurements. Cloning, expression, and purification of the 2PMQ (HpbD). The protein sample was provided by the NYSGXRC structural genomics centre (PSI-2; U54GM074945).
Cloning, expression, and purification of the 2PMQ orthologue (HpbD) from P. denitrificans. The protein sample was provided by the NYSGXRC structural genomics centre.
Cloning, expression and purification of the HypF from P. denitrificans. The hypF gene was amplified by PCR using primers P17 and P18 and genomic DNA of P. denitrificans as a template. The PCR product was digested with NdeI and BglII and ligated to pET15b expression vector, yielding plasmid pRK9. The cloned HypF was expressed in E. coli BL21 (DE3) cells for protein purification. Luria-Bertani medium (4 l) was shaken at 20 uC and induced with 0.5 mM isopropyl b-D-thiogalactoside when the culture reached a D 600 of 0.6. The cells were harvested after 24 h by centrifugation. The cells were resuspended in 100 ml of buffer containing 5 mM imidazole, 0.5 M NaCl, 20 mM Tris-HCl pH 7.9, and 0.1 mM dithiothreitol (DTT). The suspension was lysed by sonication, and debris was cleared by centrifugation. The supernatant was applied to a Sepharose FF column charged with Ni 21 Polarimetric assay for HpbD activity. Hyp-B 2-epimerase and L-Pro-B racemase activities were measured at 25 uC by quantifying the change in optical rotation. The assay was performed in a total volume of 0.8 ml in a cell with a path length of 100 mm, using a Jasco P-1010 polarimeter with a Hg 405-nm filter. Buffer conditions for the assay were 50 mM Tris-HCl pH 8.0 containing 10 mM MgCl 2 .
Polarimetric assay for HpbF activity. Hyp epimerase activity was measured at 25 uC by quantifying the change in optical rotation. The assay was performed in a total volume of 0.8 ml in a cell with a path length of 100 mm, using a Jasco P-1010 polarimeter with a Hg 405-nm filter. Buffer conditions for the assay were 50 mM sodium phosphate buffer pH 8.0 containing 1 mM DTT. Structure determination. Expression of HpbD. Plasmid 9437a2BNt21p1, obtained from NYSGRXC stock clones 37 , consists of a codon optimized HpbD gene in pSGX2, a derivative of pET26b (Novagen), with the amino-terminal methionine of HpdD changed to the sequence MAHHHHHHSL. The vector was transformed into Rosetta2 (DE3)pLysS competent cells (EMD Millipore) and plated on Luria-Bertani agar plates. Five to ten colonies were added to 75 ml of Luria-Bertani medium with 0.5% glucose and grown overnight at 37 uC. HpbD was expressed using 4 l of autoinduction medium at 25 uC (refs 38, 39) . The starter culture and autoinduction medium were distributed equally among ten 2 l baffled flasks, and shaken at 300 r.p.m. for about 24 h to D 600 . 15. All growth media contained 100 mg ml 21 kanamycin and 50 mg ml 21 chloramphenicol. Cells were pelleted and stored at 280 uC.
Purification of HpbD. All purification was performed at 4 uC. Cells were resuspended in 33 (w/w) buffer A (50 mM HEPES pH 7.8, 150 mM NaCl, 20 mM imidazole, 10% (w/v) glycerol) supplemented with 0.1% (v/v) Tween 20 and disrupted by sonication. Cellular debris was removed by centrifugation, and the supernatant was applied to a 10-ml metal-affinity column (Ni 21 Sepharose High Performance; GE Healthcare) pre-equilibrated with buffer A. The column was washed with five column volumes of buffer A and subsequently eluted with two column volumes of the same buffer containing 300 mM imidazole. Eluted protein was pooled and applied to a 120-ml Superdex 200 column (GE Healthcare) equilibrated with buffer B (10 mM HEPES pH 7.5, 150 mM NaCl, 5% (v/v) glycerol). Fractions with more than 95% purity by SDS-PAGE analysis were pooled, concentrated by centrifugal ultrafiltration, snap-frozen in liquid nitrogen and stored at 280 uC.
Crystallization and structure solution of HpbD. Crystals were obtained by vapour diffusion at 18 uC using the sitting-drop vapour-diffusion method in 96well IntelliPlates (Art Robbins). Equal volumes of protein (24.6 mg ml 21 in 10 mM HEPES pH 7.5, 150 mM NaCl, 5% (w/v) glycerol, 5 mM EDTA, 2 mM NiCl 2 ) and crystallization buffer (70% (v/v) 2-methyl-2,4-pentanediol, 0.1 M HEPES pH 7.5) were combined and equilibrated against 70 ml of crystallization buffer in the reservoir. Crystals grew as parallelograms measuring 0.05 mm 3 0.15 mm over a 1-2week period. Crystals were soaked for 2 min in the reservoir solution supplemented with 200 mM trans-4-hydroxy-L-proline betaine (tHyp-B) and 50 mM MgCl 2 . Crystals were flash-cooled by immersion in liquid nitrogen, and subsequently stored and shipped to the Advanced Photon Source beamline 31-ID (Lilly-CAT). Data were collected at 100 K and a wavelength of 0.97929 Å . Crystals were rotated through 180u in 1u increments and the data were processed with MOSFLM 40 and scaled with SCALA 41 in space group P2 1 . The unliganded structure (APO) was determined by selenomethionine single-wavelength anomalous diffraction phasing by the NYSGXRC in 2007 from a carboxy-terminally hexahistidine-tagged protein (2PMQ; Supplementary Table 4 ), with one dimer per asymmetric unit. A single subunit from the unliganded structure was used as a search model in molecular replacement for the structural determination of the liganded structure. PHASER 42 within the refinement package PHENIX 43 located eight subunits, which could subsequently be assembled into the molecular octamer. Several rounds of manual rebuilding and ligand and water fitting within the molecular graphics program COOT 44 followed by refinement in PHENIX were performed to finalize the structure. Several iodine atoms (seven or eight per subunit), originating from the synthesis of the substrate, were modelled into difference density peaks with features suggestive of bound iodine. The geometry restraints for tHyp-B were produced with the PRODRG2 server 45 . The density was fitted equally well by tHyp-B and the product cHyp-B. It is presumed that the protein is active in the crystalline form and that the density is most probably a mix of substrate and product; however, only tHyp-B was used in refinement. The final structure has 98.6% of its residues in favoured regions of the Ramachandran plot, and 0.0% in disallowed regions (4H2H; Supplementary Table 4 ). The liganded structure (4H2H) superimposes with the APO structure (subunit A on subunit A) with a root mean squared deviation of 0.25 Å over 366 aligned Ca atoms with no substantial changes to the structure on ligand binding. Microbiology. Bacterial strains and growth conditions. P. denitrificans PD1222 wild-type and mutant strains were grown in minimal medium containing (in grams per litre) K 2 HPO 4 6.0, KH 2 PO 4 4.0, sodium molybdate 0.15, MgSO 4 .7H 2 O 0.2, LETTER RESEARCH
